Design: Retrospective multicentre cohort
Population: 1,299 adults aged 65 or over admitted to acute hospitals in Japan
Primary outcome: Hospital-associated disability (Barthel decline of 5 or more)
Effect: Charlson OR 1.44 (95% CI 1.20 to 1.73) non-frail; 0.98 (0.90 to 1.06) frail; interaction P < .001

A retrospective multicentre cohort from Japanese acute hospitals (Journal of the American Medical Directors Association, 30 September 2026) followed 1,299 adults aged 65 or over to see whether comorbidity burden, measured by the Charlson index, predicted hospital-associated disability, a fall of 5 or more points in the Barthel index during admission.

In non-frail patients (Clinical Frailty Scale 3 or less), each point of comorbidity raised the odds of disability (odds ratio 1.44). In mildly frail patients the association weakened (1.11), and in frail patients it disappeared (0.98). The difference between groups was highly significant.

In frail patients, the counting of diagnoses stops telling you who will decline. Frailty itself is the stronger signal. It supports recording a frailty score on admission and acting on it, rather than relying on the problem list.

Record a Clinical Frailty Scale score for every older adult on admission.
In frail patients, assume a high risk of in-hospital functional decline regardless of the diagnosis count.
Start mobilisation, nutrition and delirium prevention early in frail inpatients.
Use comorbidity counts for risk mainly in those who are not frail.

Why it matters

It shows a frailty score carries information the problem list misses in the patients at greatest risk.

The statistics, in plain English

An odds ratio of 1.44 per comorbidity point in non-frail patients means risk rose quickly with each condition. In frail patients the ratio of 0.98, with an interval crossing 1, means no relationship was detectable.